High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil

Journal of Infection

Volumn 57, Issue 4, 2008, Pages 324-331

  Weidlich, Luciana ^a,b   Baethgen, Ludmila F ^b   Mayer, Leonard W ^c   Moraes, Camile ^b   Klein, Cecília C ^b   Nunes, Luciana S ^a   Rios, Sílvia da S ^d   Kmetzsch, Claudete I ^e   Rossetti, Maria L R ^b   Zaha, Arnaldo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Fundacao Estadual de Producao   (Brazil)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Instituto de Pesquisas Biologicas Laboratorio Central do Estado do Rio Grande do Sul (IPB LACEN RS   (Brazil)

^e Divisão de Atenção à Saúde Secretaria da Saúde do Estado do Rio Grande do Sul   (Brazil)

Author keywords

Epidemiology; Hypervirulent lineages; Neisseria meningitidis; PorA VR types; Serogroup B vaccine

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BRAZIL; DISEASE SURVEILLANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NEISSERIA MENINGITIDIS; NEISSERIACEAE INFECTION; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; RISK FACTOR; SEROTYPE;

BACTERIAL TYPING TECHNIQUES; BRAZIL; CHILD, PRESCHOOL; DNA, BACTERIAL; EPIDEMIOLOGY, MOLECULAR; HUMANS; INFANT; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL INFECTIONS; NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS, SEROGROUP B; NEISSERIA MENINGITIDIS, SEROGROUP C; NEISSERIA MENINGITIDIS, SEROGROUP W-135; POPULATION SURVEILLANCE; PORINS; PREVALENCE; SEQUENCE ANALYSIS, DNA; SEROTYPING;

EID: 53249130566     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.07.014     Document Type: Article

References (43)

1. Maiden M.C.J., and Caugant D.A. The population biology of Neisseria meningitidis: implications for meningococcal disease, epidemiology and control. In: Frosch M., and Maiden M. (Eds). Handbook of meningococcal disease (2006), Wiley-VGH-Verlag, Weinheim 427-480
2. Baethgen L.F., Weidlich L., Moraes C., Klein C., Nunes L.S., Cafrune P.I., et al. Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing. Trop Med Int Health 13 1 (2008) 31-40 10.1111/j.1365-3156.2007.01970.x
3. Brooks R., Woods C.W., Benjamin Jr. D.K., and Rosenstein N.E. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis 43 1 (2006) 49-54
4. Zarantonelli M.L., Lancellotti M., Deghmane A.E., Giorgini D., Hong E., Ruckly C., et al. Hyperinvasive genotypes of Neisseria meningitidis in France. Clin Microbiol Infect 14 5 (2008) 467-472 10.1111/j.1469-0691.2008.01955.x
5. Stephens D.S., Greenwood B., and Brandtzaeg P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369 9580 (2007) 2196-2210 10.1016/S0140-6736(07)61016-2
6. Urwin R., Russell J.E., Thompson E.A., Holmes E.C., Feavers I.M., and Maiden M.C. Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect Immun 72 10 (2004) 5955-5962 10.1128/IAI.72.10.5955-5962.2004
7. Brehony C., Jolley K.A., and Maiden M.C. Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol Rev 31 1 (2007) 15-26 10.1111/j.1574-6976.2006.00056.x
8. Maiden M.C., Bygraves J.A., Feil E., Morelli G., Russell J.E., Urwin R., et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95 6 (1998) 3140-3145
9. Dyet K.H., and Martin D.R. Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic. Epidemiol Infect 134 2 (2006) 377-383 10.1017/S0950268805004954
10. Harrison L.H. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev 19 1 (2006) 142-164 10.1128/CMR.19.1.142-164.2006
11. Aase A., Høiby E.A., and Michaelsen T.E. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine. Scand J Immunol 47 4 (1998) 388-396
12. Jessouroun E., da Silveira I.F., Larangeira A.P., Pereira S., Fernandes S.A., Rabinovitch L., et al. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock. Vaccine 22 20 (2004) 2617-2625 10.1016/j.vaccine.2003.12.009
13. Feavers I.M., Fox A.J., Gray S., Jones D.M., and Maiden M.C. Antigenic diversity of meningococcal outer membrane protein PorA has implications for epidemiological analysis and vaccine design. Clin Diagn Lab Immunol 3 4 (1996) 444-450
14. Alkmin M.G.A., Shimizu S.H., Landgraf I.M., Gaspari E.N., and Melles C.E.A. Production and immunochemical characterization of Neisseria meningitidis group B antiserum for the diagnosis of purulent meningitis. Braz J Med Biol Res 27 (1994) 1627-1634
15. Takeda A.K., Umekita L.F., Boscardin N.B., Meles C.A.E., and Taunay A.E. Imunoeletroforese cruzada no diagnóstico de meningite causada por Haemophilus influenzae tipo b. Revista do Instituto Adolfo Lutz 39 (1979) 165-169
16. Mothershed E.A., Sacchi C.T., Whitney A.M., Barnett G.A., Ajello G.W., Schmink S., et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol 42 1 (2004) 320-328 10.1128/JCM.42.1.320-328.2004
17. Jolley K.A., Chan M.S., and Maiden M.C. mlstdbNet - distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics 5 (2004) 86 10.1186/1471-2105-5-86
18. Feavers I.M., and Maiden M.C. A gonococcal porA pseudogene: implications for understanding the evolution and pathogenicity of Neisseria gonorrhoeae. Mol Microbiol 30 3 (1998) 647-656
19. Sacchi C.T., Lemos A.P., Brandt M.E., Whitney A.M., Melles C.E., Solari C.A., et al. Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin Diagn Lab Immunol 5 6 (1998) 845-855
20. Cartwright K., Noah N., and Peltola H. Meningococcal disease advisory board. Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. Vaccine 19 31 (2001) 4347-4356 10.1016/S0264-410X(01)00205-5
21. Gray S.J., Trotter C.L., Ramsay M.E., Guiver M., Fox A.J., Borrow R., et al. Epidemiology of meningococcal disease in England and Wales 1993/94 to 2003/04: contribution and experiences of the meningococcal reference unit. J Med Microbiol 55 Pt 7 (2006) 887-896 10.1099/jmm.0.46288-0
22. Tzeng L., and Stephens D.S. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect 2 (2000) 687-700 10.1016/S1286-4579(00)00356-7
23. Birtles A., Hardy K., Gray S.J., Handford S., Kaczmarski E.B., Edwards-Jones V., et al. Multilocus sequence typing of Neisseria meningitidis directly from clinical isolates and clinical specimens and application of the method to the investigation of meningococcal disease case clusters. J Clin Microbiol 43 12 (2005) 6007-6014 10.1128/JCM.43.12.6007-6014.2005
24. de Filippis I., and Vicente A.C. Multilocus sequence typing and repetitive element-based polymerase chain reaction analysis of Neisseria meningitidis isolates in Brazil reveal the emergence of 11 new sequence types genetically related to the ST-32 and ST-41/44 complexes and high prevalence of strains related to hypervirulent lineages. Diagn Microbiol Infect Dis 53 3 (2005) 161-167 10.1016/j.diagmicrobio.2005.06.015
25. Lemos A.P., Yara T.Y., Gorla M.C., de Paiva M.V., de Souza A.L., Gonçalves M.I., et al. Clonal distribution of invasive Neisseria meningitidis serogroup C strains circulating from 1976 to 2005 in greater Sao Paulo, Brazil. J Clin Microbiol 45 4 (2007) 1266-1273 10.1128/JCM.02510-06
26. Dyet K., Devoy A., McDowell R., and Martin D. New Zealand's epidemic of meningococcal disease described using molecular analysis: implications for vaccine delivery. Vaccine 23 17-18 (2005 Mar) 2228-2230 10.1016/j.vaccine.2005.01.050
27. Takahashi H., Kuroki T., Watanabe Y., Tanaka H., Inouye H., Yamai S., et al. Characterization of Neisseria meningitidis isolates collected from 1974 to 2003 in Japan by multilocus sequence typing. J Med Microbiol 53 Pt 7 (2004) 657-662 10.1099/jmm.0.45541-0
28. Zhang X., Shao Z., Zhu Y., Xu L., Xu X., Mayer L.W., et al. Genetic characteristics of serogroup A meningococci circulating in China, 1956-2005. Clin Microbiol Infect 14 6 (2008) 555-561 10.1111/j.1469-0691.2008.01977.x
29. Sacchi C.T., Lemos A.P., Popovic T., De Morais J.C., Whitney A.M., Melles C.E., et al. Serosubtypes and PorA types of Neisseria meningitidis serogroup B isolated in Brazil during 1997-1998: overview and implications for vaccine development. J Clin Microbiol 39 8 (2001) 2897-2903 10.1128/JCM.39.8.2897-2903.2001
30. Vicente D., Esnal O., Michaus L., López de Goicoechea M.J., Cisterna R., and Pérez-Trallero E. Prevalence of genosubtypes (PorA types) of serogroup B invasive meningococcus in the north of Spain from 2000 to 2003. J Med Microbiol 54 Pt 4 (2005) 381-384 10.1099/jmm.0.45855-0
31. Sacchi C.T., Whitney A.M., Popovic T., Beall D.S., Reeves M.W., Plikaytis B.D., et al. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis 182 4 (2000) 1169-1176 10.1086/315833
32. de Filippis I., de Andrade C.F., Silva L., Prevots D.R., and Vicente A.C. PorA variable antigenic regions VR1, VR2, and VR3 of Neisseria meningitidis serogroups B and C isolated in Brazil from 1999 to 2004. Infect Immun 75 7 (2007) 3683-3685 10.1128/IAI.01721-06
33. Lemos A.P., Brandão A.P., Gorla M.C., Paiva M.V., Simonsen V., and Melles C.E. Phenotypic characterization of Neisseria meningitidis strains isolated from invasive disease in Brazil from 1990 to 2001. J Med Microbiol 55 Pt 6 (2006) 751-757 10.1099/jmm.0.46451-0
34. Pereira C.S., Regueira M., and Mollerach M. PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine. J Med Microbiol 57 (2008) 338-342 10.1099/jmm.0.47631-0
35. Aguilera J.F., Perrocheau A., Meffre C., Hahné S., and W135 Working Group. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000. Emerging Infect Dis 8 8 (2002) 761-767
36. Kilic A., Urwin R., Li H., Saracli M.A., Stratton C.W., and Tang Y.W. Clonal spread of serogroup W135 meningococcal disease in Turkey. J Clin Microbiol 44 1 (2006) 222-224 10.1128/JCM.44.1.222-224.2006
37. Mayer L.W., Reeves M.W., Al-Hamdan N., Sacchi C.T., Taha M.K., Ajello G.W., et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electrophoretic type-37 complex. J Infect Dis 185 11 (2002) 1596-1605 10.1086/340414
38. Traoré Y., Njanpop-Lafourcade B.M., Adjogble K.L., Lourd M., Yaro S., Nacro B., et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis 43 7 (2006) 817-822 10.1086/507339
39. Taha M.K., Achtman M., Alonso J.M., Greenwood B., Ramsay M., Fox A., et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356 9248 (2000) 2159 10.1016/S0140-6736(00)03502-9
40. Barroso D.E., and Rebelo M.C. Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W135 in the Rio de Janeiro region, Brazil. Mem Inst Oswaldo Cruz 102 6 (2007) 773-775 10.1590/S0074-02762007005000104
41. Chiávetta L., Chávez E., Ruzic A., Mollerach M., and Regueira M. Surveillance of Neisseria meningitidis in Argentina, 1993-2005: distribution of serogroups, serotypes and serosubtypes isolated from invasive disease. Rev Argent Microbiol 39 1 (2007) 21-27
42. von Gottberg A., du Plessis M., Cohen C., Prentice E., Schrag S., de Gouveia L., et al. Group for Enteric, respiratory and meningeal disease surveillance in South Africa. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis 46 3 (2008) 377-386 10.1086/525260
43. Bilukha O.O., and Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 54 (2005) 1-21